Akira Toyama

3PUBLICATIONS
6CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOral medicine and pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 14, 2025
Investigation of non-completion factors for durvalumab maintenance therapy in locally advanced non-small cell lung cancer.

Masaaki Kotake, Yuki Sakai, Satoshi Watanabe

|Nov 13, 2025
Patient-reported oral adverse events during cancer chemotherapy: longitudinal evaluation using patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) and concordance with clinician assessments.

Yuki Sakai, Kouji Katsura, Yoshitomi Kanemitsu

Pageof 1